Perceptive Advisors’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-500,000
Closed -$4.86M – 136
2022
Q1
$4.86M Hold
500,000
– – 0.1% 105
2021
Q4
$4.9M Hold
500,000
– – 0.08% 121
2021
Q3
$4.92M Buy
+500,000
New +$4.94M 0.07% 120

Other funds holding DALS

Perceptive Advisors's DALS Position: Q2 2022 in Review

Perceptive Advisors sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q2 2022, closing a stake of 500,000 shares — an estimated $4.86M sold.

Perceptive Advisors first reported a position in DALS in Q3 2021 and held it in 3 quarters. The position peaked at $4.92M in Q3 2021. 45 funds tracked by Wall St. Rank hold DALS as of Q2 2022.

  • Perceptive Advisors reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q2 2022 after selling out during the quarter.
  • Perceptive Advisors sold 500,000 DA32 Life Science Tech Acquisition Corp shares in Q2 2022, an estimated $4.86M.
  • Perceptive Advisors first reported a position in DA32 Life Science Tech Acquisition Corp in Q3 2021 and held it in 3 quarters.
  • Perceptive Advisors's DA32 Life Science Tech Acquisition Corp position peaked at $4.92M in Q3 2021.
  • 45 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q2 2022.

Based on Perceptive Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.